HOME >> BIOLOGY >> NEWS
Fish oil and vitamin E reduce levels of pro-inflammatory proteins in rheumatoid arthritis, UB study shows

BUFFALO, N.Y. -- While scientists ponder potential new treatments for rheumatoid arthritis at the American College of Rheumatology meeting in Philadelphia, they should not overlook potential nutritional approaches.

A study lead by Jaya Venkatraman, Ph.D., UB associate professor in the Department of Physical Therapy, Exercise and Nutrition Sciences, has shown that in a mouse model, a combination of fish oil and vitamin E reduced the levels of inflammation-inducing cytokines, proteins that cause the joint swelling, pain and tenderness characteristic of this disease.

That study, published in the Journal of the American College of Nutrition, was named best scientific paper of the year this October by the American College of Nutrition.

Venkatraman said results using the mouse model show that fish oil and vitamin E are promising potential therapies for those suffering from rheumatoid arthritis.

"This mouse model for arthritis displays symptoms very similar to what happens in humans," she said. "The combination of fish oil, with its omega-3 fatty acids, and vitamin E appears to help restore the balance between pro- and anti-inflammatory cytokines.

"It probably can't prevent development of rheumatoid arthritis, but it may delay symptoms and allow a reduction in other medication. People who normally had to take 10 aspirins a day, for example, may be able to take five. This therapy also seems to improve function."

In this study, Venkatraman used mice that over-express the lpr gene that causes fast aging, immuonological abnormalities and induces development of autoimmune diseases, including rheumatoid arthritis and lupus. These diseases are characterized by cartilage destruction, known to be caused in part by an abnormal production of pro-inflammatory proteins that act as though cartilage has been invaded by foreign proteins and fight to destroy them.

Clinical trials in humans and laboratory research with animals have shown that die
'"/>

Contact: Lois Baker
ljbaker@buffalo.edu
716-645-5000 x1417
University at Buffalo
30-Oct-2000


Page: 1 2

Related biology news :

1. Lycopene slows human prostate tumour growth in mice and combined with vitamin E is even better
2. Chemical derived from vitamin-E shows early promise as cancer drug
3. Folic acid vitamin use by women reaches all-time high, March of Dimes survey finds
4. Alterations in vitamin D receptor gene increase prostate, breast cancer risk
5. Could vitamins raise levels of bad cholesterol? Animal study suggests they might
6. New antioxidants are 100 times more effective than vitamin E
7. Study finds huge variability in vitamin E absorption
8. People with undetermined muscle/bone pain tend to be severely vitamin D deficient
9. Daily vitamins could prevent vision loss among thousands
10. Drug that mimics vitamin D hormone may boost effectiveness of prostate cancer treatment
11. Strategies to boost womens multivitamin use fall short

Post Your Comments:
(Date:5/23/2013)... new report from the Institute of Medicine says schools ... least 60 minutes of vigorous or moderate intensity activity ... of American youth meet current evidence-based guidelines of at ... activity daily, according to the report, which was released ... nearly half of their waking hours, the committee recommends ...
(Date:5/23/2013)... Frontiers, one of the world,s largest and fastest ... new journal, Frontiers in Bioengineering and Biotechnology ... all specialties, Frontiers in Bioengineering and Biotechnology ... diverse and emerging bioengineering and biotechnology research to ... in Bioengineering and Biotechnology will provide an ...
(Date:5/22/2013)... May 22, 2013 U.S. Forest Service scientists are ... with funding from the TKF Foundation, will examine how ... and individuals recover from tragedy. , The TKF Foundation ... six projects selected for grant funding. In addition to ... spaces in recovery and resiliency, the 3-year, $585,000 grant ...
Breaking Biology News(10 mins):Schools should provide students with daily physical activity, IOM recommends 2Frontiers launches new open-access journal in Bioengineering and Biotechnology 2'Landscapes of Resilience' to study how people use nature as a source of recovery 2
(Date:5/24/2013)... TEL AVIV, Israel , May 24, 2013 ... NSPR), a leader in embolic protection stents, announced that ... Executive Officer, and Craig Shore , the ... LLC One-on-One Investor Conference on Thursday May 30, 2013 at ... WI. The format of the conference ...
(Date:5/24/2013)... Vestiage, Inc. (stock symbol "VEST") a publicly ... and development, sales and marketing of premium branded ... that it is awarding exclusive Vestiage territories in ... Skin Illuminating Facial Care. Qualified applicants can request ... email to info(at)vestiageinc(dot)com and putting RELUMA in the ...
(Date:5/23/2013)... , May 23, 2013  BioScrip, Inc. (NASDAQ: ... present at the Jefferies 2013 Global Healthcare Conference to ... New York. Richard Smith ... Hai Tran , Chief Financial Officer, will present ... Daylight Time.   About BioScrip BioScrip, ...
(Date:5/23/2013)... Ind. , May 23, 2013  Rahal Letterman ... in human cord blood stem cell banking and therapeutics, ... of the No. 16 Acorn Stairlifts Indy car driven ... for the remainder of the IZOD IndyCar 2013 season. ... (RLL) will work to support awareness of umbilical cord ...
Breaking Biology Technology:InspireMD To Participate In Benchmark Investor Conference On May 30th 2InspireMD To Participate In Benchmark Investor Conference On May 30th 3InspireMD To Participate In Benchmark Investor Conference On May 30th 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3
Cached News: